Today’s limit-up and limit-down stock analysis: 65 stocks hit the limit-up, 14 stocks hit the limit-down, innovative medicine concept is active, Wanze Shares, Guangsheng Tang, and others hit the limit-up

April 1st, the total number of limit-up stocks in the A-shares market was 65, and the number of limit-down stocks was 14. The innovative drug concept was active, with Wanze Shares, Guangsheng Tang, and others hitting the limit-up; the CRO/CMO concept strengthened, with Kelai Ying hitting two consecutive limit-ups.

In terms of consecutive limit-up stocks, Aoruite had 6 limit-ups in 11 days, *ST Jiyou had 5 limit-ups in 6 days, Jinyao Pharmaceutical had 4 consecutive limit-ups, *ST Dongyi had 3 limit-ups in 6 days, Ji’an Medical had 3 limit-ups in 4 days, Xihua Technology had 2 limit-ups in 4 days, Guosheng Technology and Ningbo Fuda had 2 limit-ups in 3 days, Xinghui Environmental Materials and Tongda Shares had 2 consecutive limit-ups, Huajin Technology and Gaint Network hit the limit-up.

*ST Jinlun experienced 5 consecutive days of limit-down, *ST Yuanshang experienced 4 consecutive days of limit-down, *ST Wanfang experienced 3 consecutive days of limit-down, *ST Guohua and *ST Taihe experienced 2 consecutive days of limit-down, *ST Huarong and Huitian Thermal Power experienced limit-downs.